85 related articles for article (PubMed ID: 38607073)
21. Transcriptomic Profiling of DNA Damage Response in Patient-Derived Glioblastoma Cells before and after Radiation and Temozolomide Treatment.
Lozinski M; Bowden NA; Graves MC; Fay M; Day BW; Stringer BW; Tooney PA
Cells; 2022 Apr; 11(7):. PubMed ID: 35406779
[TBL] [Abstract][Full Text] [Related]
22. Treatment of glioblastoma with re-purposed renin-angiotensin system modulators: Results of a phase I clinical trial.
O'Rawe M; Wickremesekera AC; Pandey R; Young D; Sim D; FitzJohn T; Burgess C; Kaye AH; Tan ST
J Clin Neurosci; 2022 Jan; 95():48-54. PubMed ID: 34929651
[TBL] [Abstract][Full Text] [Related]
23. Novel Insights into the Antagonistic Effects of Losartan against Angiotensin II/AGTR1 Signaling in Glioblastoma Cells.
Panza S; Malivindi R; Caruso A; Russo U; Giordano F; Győrffy B; Gelsomino L; De Amicis F; Barone I; Conforti FL; Giordano C; Bonofiglio D; Catalano S; Andò S
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572782
[TBL] [Abstract][Full Text] [Related]
24. The Effect of Local Renin Angiotensin System in the Common Types of Cancer.
Almutlaq M; Alamro AA; Alamri HS; Alghamdi AA; Barhoumi T
Front Endocrinol (Lausanne); 2021; 12():736361. PubMed ID: 34539580
[TBL] [Abstract][Full Text] [Related]
25. WNT Signaling as a Therapeutic Target for Glioblastoma.
Latour M; Her NG; Kesari S; Nurmemmedov E
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445128
[TBL] [Abstract][Full Text] [Related]
26. The Renin-Angiotensin System in the Tumor Microenvironment of Glioblastoma.
O'Rawe M; Kilmister EJ; Mantamadiotis T; Kaye AH; Tan ST; Wickremesekera AC
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439159
[TBL] [Abstract][Full Text] [Related]
27. Blood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis.
Ho JK; Moriarty F; Manly JJ; Larson EB; Evans DA; Rajan KB; Hudak EM; Hassan L; Liu E; Sato N; Hasebe N; Laurin D; Carmichael PH; Nation DA
Hypertension; 2021 Sep; 78(3):629-643. PubMed ID: 34148364
[TBL] [Abstract][Full Text] [Related]
28. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.
Weller M; van den Bent M; Preusser M; Le Rhun E; Tonn JC; Minniti G; Bendszus M; Balana C; Chinot O; Dirven L; French P; Hegi ME; Jakola AS; Platten M; Roth P; Rudà R; Short S; Smits M; Taphoorn MJB; von Deimling A; Westphal M; Soffietti R; Reifenberger G; Wick W
Nat Rev Clin Oncol; 2021 Mar; 18(3):170-186. PubMed ID: 33293629
[TBL] [Abstract][Full Text] [Related]
29. Targeting AGTR1/NF-κB/CXCR4 axis by miR-155 attenuates oncogenesis in glioblastoma.
Singh A; Srivastava N; Yadav A; Ateeq B
Neoplasia; 2020 Oct; 22(10):497-510. PubMed ID: 32896760
[TBL] [Abstract][Full Text] [Related]
30. Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma.
DeCordova S; Shastri A; Tsolaki AG; Yasmin H; Klein L; Singh SK; Kishore U
Front Immunol; 2020; 11():1402. PubMed ID: 32765498
[TBL] [Abstract][Full Text] [Related]
31. Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma.
Urup T; Gillberg L; Kaastrup K; Lü MJS; Michaelsen SR; Andrée Larsen V; Christensen IJ; Broholm H; Lassen U; Grønbaek K; Poulsen HS
Mol Oncol; 2020 May; 14(5):964-973. PubMed ID: 32133779
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia Can Induce Migration of Glioblastoma Cells Through a Methylation-Dependent Control of
Velásquez C; Mansouri S; Gutiérrez O; Mamatjan Y; Mollinedo P; Karimi S; Singh O; Terán N; Martino J; Zadeh G; Fernández-Luna JL
Front Oncol; 2019; 9():1036. PubMed ID: 31649891
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia signaling in human diseases and therapeutic targets.
Lee JW; Ko J; Ju C; Eltzschig HK
Exp Mol Med; 2019 Jun; 51(6):1-13. PubMed ID: 31221962
[TBL] [Abstract][Full Text] [Related]
34. A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma.
Stringer BW; Day BW; D'Souza RCJ; Jamieson PR; Ensbey KS; Bruce ZC; Lim YC; Goasdoué K; Offenhäuser C; Akgül S; Allan S; Robertson T; Lucas P; Tollesson G; Campbell S; Winter C; Do H; Dobrovic A; Inglis PL; Jeffree RL; Johns TG; Boyd AW
Sci Rep; 2019 Mar; 9(1):4902. PubMed ID: 30894629
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis.
Ge X; Pan MH; Wang L; Li W; Jiang C; He J; Abouzid K; Liu LZ; Shi Z; Jiang BH
Cell Death Dis; 2018 Nov; 9(11):1128. PubMed ID: 30425242
[TBL] [Abstract][Full Text] [Related]
36. Within the Brain: The Renin Angiotensin System.
Jackson L; Eldahshan W; Fagan SC; Ergul A
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29543776
[TBL] [Abstract][Full Text] [Related]
37. A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells.
Ahmed EM; Bandopadhyay G; Coyle B; Grabowska A
Cell Oncol (Dordr); 2018 Jun; 41(3):319-328. PubMed ID: 29492900
[TBL] [Abstract][Full Text] [Related]
38. Targeting glioma stem cells through combined BMI1 and EZH2 inhibition.
Jin X; Kim LJY; Wu Q; Wallace LC; Prager BC; Sanvoranart T; Gimple RC; Wang X; Mack SC; Miller TE; Huang P; Valentim CL; Zhou QG; Barnholtz-Sloan JS; Bao S; Sloan AE; Rich JN
Nat Med; 2017 Nov; 23(11):1352-1361. PubMed ID: 29035367
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of Mas1 Receptor-Mediated Signaling in the Vascular Endothelium.
Hoffmann BR; Stodola TJ; Wagner JR; Didier DN; Exner EC; Lombard JH; Greene AS
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):433-445. PubMed ID: 28082260
[TBL] [Abstract][Full Text] [Related]
40. (Pro)renin receptor is crucial for glioma development via the Wnt/β-catenin signaling pathway.
Kouchi M; Shibayama Y; Ogawa D; Miyake K; Nishiyama A; Tamiya T
J Neurosurg; 2017 Oct; 127(4):819-828. PubMed ID: 28059652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
